Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis
Abroad (travel likely)RecruitingPHASE4
Conditions
Ulcerative Colitis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Bausch Health Site 008, Garden Grove, California, United States
Bausch Health Site 003, Indianapolis, Indiana, United States
Bausch Health Site 006, The Bronx, New York, United States
Bausch Health Site 010, Greenville, North Carolina, United States
Study leads
Varsha Bhatt
Study Director
Bausch Health Americas, Inc.